| Literature DB >> 14678976 |
Johann Soret1, Mathieu Gabut, Cecile Dupon, Glenda Kohlhagen, James Stévenin, Yves Pommier, Jamal Tazi.
Abstract
DNA topoisomerase I (Topo I) specifically phosphorylates arginine-serine-rich (SR proteins) splicing factors and is potentially involved in pre-mRNA-splicing regulation. Using a Topo I-deficient murine B lymphoma-derived subclone (P388-45/C) selected for its resistance to high dosage of the antitumor drug camptothecin, we show that Topo I depletion results in the hypophosphorylation of SR proteins and impairs exonic splicing enhancer (ESE)-dependent but not constitutive splicing. The Affymetrix GeneChip system analysis revealed that several alternatively spliced genes, characterized by small exons and large introns, are down-regulated in Topo I-deficient cells. Given that ectopic expression of green fluorescent protein-Topo I fusion in Topo I-deficient cells restores both wild-type phosphorylation of SR proteins and ESE-dependent splicing, we conclude that Topo I-mediated phosphorylation plays a specific role in ESE-regulated splicing.Entities:
Mesh:
Substances:
Year: 2003 PMID: 14678976
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701